Abstract
Background: The glyA gene in Tannerella forsythia is attributed for its virulence by producing the enzyme serine hydroxymethyltransferase (SHMT), which plays a vital role in bacterial cell metabolism.
Objectives: The study is thus aimed to determine the frequency of the glyA gene from the clinical strains of T. forsythia isolated from periodontitis patients.
Materials and methods: Forty-five patients with varying degrees of periodontitis were included in the study, and the plaque samples collected from them were anaerobically processed by inoculating onto sterile anaerobic blood agar plates using a gaspak system, with incubation at 37°C for 5-7 days. The DNA was extracted from the obtained isolated colony, and PCR was performed to confirm the presence of the glyA gene.
Results: In total, 46.6% (n = 7) of the cases in group III aggressive periodontitis (n = 15) and 6.66% (n = 1) in group II stage II periodontitis (n = 15) showed the presence of T. forsythia, and among them, 57.14% (n = 4) showed the presence of the glyA gene.
Conclusion: The findings of the study showed that the glyA gene may be associated with the pathogenesis of T. forsythia and could be thus a novel candidate for the future theragnostic approach to combat periodontitis.
Keywords: chronic periodontitis, oral health, glya, periodontitis, tannerella forsythia
Introduction
Periodontal disease is the progressive degeneration of the periodontal soft and hard tissues, which is caused by the dysbiotic microbial communities and aberrant immune responses in the gingival and periodontal tissues [1]. Periodontitis starts as an irreversible damage of the gingiva leading to the chronic inflammatory disease state resulting in higher bacterial invasion. This evokes the host's defense mechanism against the periodontal pathogens and further inflammation due to the pro-inflammatory mediators. Finally, periodontitis causes the periodontium to lose its architecture, resulting in the loss of alveolar bone and the affected tooth [2]. Periodontitis is clinically graded into four stages: stage 1, initial (gingivitis); stage 2, moderate; stage 3, severe with potential for tooth loss (aggressive periodontitis); and stage 4, severe with potential for loss of all the teeth [3]. Only 10% of adult populations worldwide have the severe form of periodontal disease, which is more prevalent in the third and fourth decades of life, and approximately 50% of adult populations worldwide suffer from periodontal disease, primarily in its mild and moderate forms and with a prevalence ranging from 45% to 50% [4].
Various studies have previously been used to investigate the connection of potent organisms associated with the periodontal habitats. Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Prevotella intermedia, Tannerella forsythia, and Fusobacterium nucleatum, and Treponema denticola are few organisms that were frequently reported to be associated with the periodontal disease [5]. In particular, P. gingivalis, T. forsythia, and T. denticola, collectively known as the "red complex," are specifically linked to the severity of periodontal disorders [6]. Amidst these pathogens, a Gram-negative, filamentous, nonpigmenting, nonmotile, anaerobe T. forsythia has been linked to advanced forms of periodontal disease, such as severe and refractory periodontitis. Only a few of T. forsythia's possible virulence factors have been identified so far such as bspA, surface (S-) layer, mutS, lysS, and glyA. As of now, the virulence factor known as bspA has been thoroughly studied and is known to mediate alveolar bone loss in mice [7]. Additionally, it causes infection co-aggregating with F. nucleatum, binding to fibronectin, interacting with extracellular matrix components and with epithelial cell attachment with further invasion [8]. The S-layer in T. forsythia has been shown to have multiple virulence effects, including co-aggregation with other oral bacteria and serum resistance [9]. However, not much studies have been documented on the glyA gene in T. forsythia in association with the periodontal disease. Experimental evidence prevails to show that glyA in other pathogens like E. coli encoding for serine hydroxymethyltransferase (SHMT), an enzyme that changes L-serine to glycine. Therefore, it is preferable to inactivate glyA in order to stop L-serine degradation when designing strains that produce L-serine. However, due to the resulting lack of glycine and C1 units, the majority of glyA knockout strains show slow cell growth, emphasizing its role in virulence [10].
The pathophysiology of T. forsythia in periodontitis is still not well understood due to the difficulty in its phenotypic characterization and genotypic variations [11]. Also, not much evidence-based studies prevail on the glyA gene in T. forsythia. This study is thus a first of its kind investigation that is aimed to detect the frequency of the glyA gene from the clinical strains of T. forsythia from the periodontitis patients showing various grades of the periodontal disease.
Materials and methods
Study population and sampling
Forty-five patients (n) with three different stages of periodontitis such as group 1: gingivitis (n = 15); group II: stage II periodontitis (n = 15); and group III: aggressive periodontitis (n = 15), visiting the Department of Periodontics, Saveetha Dental College and Hospital were included in the study. A control group was not included as there were no studies evidencing the frequency of T. forsythia among the healthy individuals. Ethical clearance and informed consent were obtained prior to the start of the study. Demographic data on the age, gender, geographical location, clinical history, etc., were recorded before the collection of the samples. Plaque samples were collected in reproducible amounts and were immediately transferred to sterile Eppendorf tubes containing tryptic digest blood broth supplemented with 5% sheep blood, 5% vitamin K, and hemin. The samples were then sent straight to the microbiology laboratory for the anaerobic processing.
Isolation of T. forsythia
Plaque samples were plated onto anaerobic blood agar base supplemented with 5% sheep blood, 5% hemin, and 5% menadione, and the plates were placed in an anaerobic jar with a gaspak system. Incubation was done for five to seven days, at 37°C, and after incubation, the plates were checked for the presence of colonies with black pigmentation. Gram staining was performed to observe the morphology of the isolates.
Molecular detection of T. forsythia and the glyA gene
Using a QIAGEN extraction kit and the manufacturer's instructions, bacterial genomic DNA (50-100 µg/µl) was extracted from fresh T. forsythia cultures and was stored at -20°C. A 5.6 µl of double-distilled water and 7.8 ul of 2x Master Mix (Takara, Japan) were used to create 15 ul of the amplification reaction mixture. The PCR conditions were set for 36 cycles in a thermocycler (Eppendorf Mastercycler, Germany) with the annealing temperature set at 58°C. Specifically designed primers (0.1 µl-100 picomoles/µl) for both T. forsythia and glyA were added separately for confirmation (Table 1). The polymerase chain reaction (PCR) amplicons were confirmed using a 100-bp DNA ladder and were visualized in 1% agarose gel electrophoresis.
Table 1. Primer details to confirm Tannerella forsythia and glyA .
| Target gene | Primer sequence | Amplicon size (bp) |
| Tannerella forsythia | F: GGGTGAGTAACGCGTATGTAACCT R: GCCCATCCGCAACCAATAAA | 127 |
| glyA | F: TTCTCGGGACTGGGATTATG | 189 |
| R: GCGTCGTTGAAGTGACGATA |
Results
Patients in group III (n = 15) with aggressive periodontitis showed the maximum isolates (n = 7; 46.6%) followed by group II with one isolate (6.66%) of T. forsythia (Table 1). The frequency of the glyA gene was more in group III (57.14%) when compared to the other groups. Compared to younger patients, elder patients had a higher frequency of isolates. Plaque samples from patients in the 20-30 and 30-40 age groups did not show any growth of T. forsythia. However, the age group of 60-70 showed the highest number of isolates (n = 4), followed by two isolates in each of the 50-60 and 60-70 age groups (Figure 1).
Figure 1. Prevalence of Tannerella forsythia in different age groups and gender.
The colonies showed typical black pigmented colonies, and Gram staining showed Gram-negative pleomorphic bacilli (Figure 2).
Figure 2. a. Typical black pigmented colony morphology of T. forsythia in anaerobic blood agar plate and b. Gram staining showing the pleomorphic Gram-negative bacilli.
The isolates of T. forsythia and frequency of the glyA gene was further confirmed by molecular characterization using PCR (Figure 3).
Figure 3. Agarose gel electrophoretogram showing (a) the amplification of glyA (amplicon size 189 bp) and (b) the genotypic confirmation of T. forsythia (amplicon size 127 bp), running along with standard DNA ladder (lane M = 100 bp DNA marker).
Of the seven isolates in group III, the frequency of the glyA gene was observed as 57.14% (n = 4) with an amplicon size of 189 bp in group III and none of the other groups showed the presence of the gene.
Discussion
Periodontitis is defined as a progressing and destructive disease of the periodontium, caused by a polymicrobial conglomeration of microbes influenced by the host factors. Patients with chronic periodontitis (CP) typically exhibit high levels of calculus and plaque, which correspond to the extent of periodontal damage. Aggressive periodontitis, on the other hand, is distinguished by a rapid rate of disease progression, with neither systemic involvement nor a familial accumulation of cases [12]. Rather than being a distinct condition, generalized aggressive periodontitis is most likely the previous stage of localized aggressive periodontitis [13]. Recent research has revealed the role of novel, noncultivable organisms in inducing the disease amidst functional biomes [14, 15]. One of the periodontal pathogens that has recently been linked to the etiology of periodontal diseases is T. forsythia. The pathogenesis and virulence of T. forsythia in colonizing the oral cavity are still unclear and yet to be elucidated.
In this context, it was recently documented that virulence factors like adhesions are associated with the cell surface of T. forsythia [16]. Animal studies have substantiated the same fact where T. forsythia resulted in alveolar bone loss in mice and rats [17] and skin abscesses in mice [18]. Additionally, there was a significant correlation of T. forsythia in aggressive periodontal cases from the subgingival plaque samples from the periodontitis-affected subjects [19]. In earlier studies, it was observed that subgingival plaque samples from the sites of periodontal disease showed higher rates of co-occurrence of P. gingivalis, T. denticola,and T. forsythia than from the samples from the healthy sites. The present study had also documented such similar results where the prevalence of T. forsythiawas seen only in group II with aggressive periodontitis and not in the other two groups. In our study, we observed a higher correlation between the prevalence of T. forsythia in the aggressive periodontitis cases (46.6%) and a very less prevalence in group II (6.66%) with stage II periodontitis. These results substantiate the correlation of T. forsythia in association with disease severity. No strains were observed in group I patients with gingivitis portraying the less prevalence with increase in tissue involvement.
In an earlier study done in E. coli, SHMT, the product of the glyA gene, transforms serine into glycine [20] and is also reported to be responsible for lysostaphin resistance in Staphylococcus aureus [21]. However, no other studies have been evidenced to understand the role of glyA in T. forsythia. Thus, the present investigation is the first-of-its-kind study to reveal the frequency of this genetic determinant in association with different grades of T. forsythia. Prevalence of glyA was up to 57.14% (n = 4) from group III and was not found in the single strain isolated from group II patients. This finding also shows that glyA may be associated with the conditions of aggressive periodontitis and not indicated in the preliminary stages. With the prediction of putative vaccine candidates for priority pathogens being very common through computational approaches [22, 23], glyA may be considered as a novel target in the research arena of designing a periodontal vaccine [24]. The limitations of the study include the smaller sample size where we could not derive a significant result to substantiate our findings on the frequency of glyA in T. forsythia in association with periodontitis condition. Further experimental studies are to be designed in order to substantiate the correlation and association of glyA in T. forsythia with the periodontal disease.
Conclusions
The findings of the present study thus give a clue on the presence of a higher frequency of glyA in T. forsythia in association with the aggressive periodontal disease condition. Periodic monitoring of such virulent determinants in all dental setups will aid in targeted therapy, diagnosis, and treatment of periodontitis. Frequent education programs for dentists creating awareness on the frequency of such virulent determinants would aid in curbing the complications of the disease as well as in the dental healthcare settings.
The authors have declared that no competing interests exist.
Author Contributions
Concept and design: A.S. Smiline Girija, Vijayashree J. Priyadharsini, Sujitha A
Acquisition, analysis, or interpretation of data: A.S. Smiline Girija, Sujitha A
Drafting of the manuscript: A.S. Smiline Girija, Sujitha A
Critical review of the manuscript for important intellectual content: A.S. Smiline Girija, Vijayashree J. Priyadharsini
Supervision: A.S. Smiline Girija, Vijayashree J. Priyadharsini
Human Ethics
Consent was obtained or waived by all participants in this study. Institutional Human Ethical Committee - Saveetha Dental College and Hospitals issued approval IHEC/SDC/UG-2127/23/MICRO/279
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.Periodontal disease: the good, the bad, and the unknown. Sedghi LM, Bacino M, Kapila YL. Front Cell Infect Microbiol. 2021;11:766944. doi: 10.3389/fcimb.2021.766944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gingivitis as a risk factor in periodontal disease. Lang NP, Schätzle MA, Löe H. J Clin Periodontol. 2009;36:3–8. doi: 10.1111/j.1600-051X.2009.01415.x. [DOI] [PubMed] [Google Scholar]
- 3.Staging and grading of periodontitis: framework and proposal of a new classification and case definition. Tonetti MS, Greenwell H, Kornman KS. J Periodontol. 2018;89:0–72. doi: 10.1002/JPER.18-0006. [DOI] [PubMed] [Google Scholar]
- 4.Porphyromonas gingivalis virulence factors and clinical significance in periodontal disease and coronary artery diseases. Aleksijević LH, Aleksijević M, Škrlec I, Šram M, Šram M, Talapko J. Pathogens. 2022;11:1173. doi: 10.3390/pathogens11101173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mechanisms underlying the association between periodontitis and atherosclerotic disease. Schenkein HA, Papapanou PN, Genco R, Sanz M. Periodontol 2000. 2020;83:90–106. doi: 10.1111/prd.12304. [DOI] [PubMed] [Google Scholar]
- 6.Evaluation of role of periodontal pathogens in endodontic periodontal diseases. Das AC, Sahoo SK, Parihar AS, Bhardwaj SS, Babaji P, Varghese JG. J Family Med Prim Care. 2020;9:239–242. doi: 10.4103/jfmpc.jfmpc_725_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Detection of Tannerella forsythia bspA and prtH genotypes among periodontitis patients and healthy subjects-a case-control study. Mahalakshmi K, Krishnan P, Chandrasekaran SC. Arch Oral Biol. 2018;96:178–181. doi: 10.1016/j.archoralbio.2018.09.012. [DOI] [PubMed] [Google Scholar]
- 8.Identification of Tannerella forsythia antigens specifically expressed in patients with periodontal disease. Yoo JY, Kim HC, Zhu W, et al. FEMS Microbiol Lett. 2007;275:344–352. doi: 10.1111/j.1574-6968.2007.00906.x. [DOI] [PubMed] [Google Scholar]
- 9.The surface layer of Tannerella forsythia contributes to serum resistance and oral bacterial coaggregation. Shimotahira N, Oogai Y, Kawada-Matsuo M, et al. Infect Immun. 2013;81:1198–1206. doi: 10.1128/IAI.00983-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Reprogramming one-carbon metabolic pathways to decouple l-serine catabolism from cell growth in Corynebacterium glutamicum. Zhang Y, Shang X, Lai S, et al. ACS Synth Biol. 2018;7:635–646. doi: 10.1021/acssynbio.7b00373. [DOI] [PubMed] [Google Scholar]
- 11.Loss of adherence ability to human gingival epithelial cells in S-layer protein-deficient mutants of Tannerella forsythensis. Sakakibara J, Nagano K, Murakami Y, Higuchi N, Nakamura H, Shimozato K, Yoshimura F. Microbiology (Reading) 2007;153:866–876. doi: 10.1099/mic.0.29275-0. [DOI] [PubMed] [Google Scholar]
- 12.Differential diagnosis between chronic versus aggressive periodontitis and staging of aggressive periodontitis: a cross-sectional study. Ramachandra SS, Gupta VV, Mehta DS, Gundavarapu KC, Luigi N. Contemp Clin Dent. 2017;8:594–603. doi: 10.4103/ccd.ccd_623_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Microbiological profile in periodontitis and peri-implantitis: a systematic review. Rajasekar A, Varghese SS. J Long Term Eff Med Implants. 2022;32:83–94. doi: 10.1615/JLongTermEffMedImplants.2022043121. [DOI] [PubMed] [Google Scholar]
- 14.Microbiology of aggressive periodontitis. Könönen E, Müller HP. Periodontol 2000. 2014;65:46–78. doi: 10.1111/prd.12016. [DOI] [PubMed] [Google Scholar]
- 15.Functional biomes beyond the bacteriome in the oral ecosystem. Girija AS, Ganesh PS. Jpn Dent Sci Rev. 2022;58:217–226. doi: 10.1016/j.jdsr.2022.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Glycobiology aspects of the periodontal pathogen Tannerella forsythia. Posch G, Sekot G, Friedrich V, Megson ZA, Koerdt A, Messner P, Schäffer C. Biomolecules. 2012;2:467–482. doi: 10.3390/biom2040467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tannerella forsythia-induced alveolar bone loss in mice involves leucine-rich-repeat BspA protein. Sharma A, Inagaki S, Honma K, Sfintescu C, Baker PJ, Evans RT. J Dent Res. 2005;84:462–467. doi: 10.1177/154405910508400512. [DOI] [PubMed] [Google Scholar]
- 18.Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, Ebersole JL. Infect Immun. 2007;75:1704–1712. doi: 10.1128/IAI.00733-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Site-specific development of periodontal disease is associated with increased levels of Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia in subgingival plaque. Mineoka T, Awano S, Rikimaru T, Kurata H, Yoshida A, Ansai T, Takehara T. J Periodontol. 2008;79:670–676. doi: 10.1902/jop.2008.070398. [DOI] [PubMed] [Google Scholar]
- 20. Regulation of serine, glycine, and one-carbon biosynthesis. Stauffer GV. EcoSal Plus. 2004;1 doi: 10.1128/ecosalplus.3.6.1.2. [DOI] [PubMed] [Google Scholar]
- 21.Functional identification of serine hydroxy methyl transferase as a key gene involved in lysostaphin resistance and virulence potential of strains. Batool N, Ko KS, Chaurasia AK, Kim KK. Int J Mol Sci. 2020;21:9135. doi: 10.3390/ijms21239135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Delineating the immuno-dominant antigen vaccine peptides against gacS sensor kinase in: an investigational approach. Smiline Girija AS. Front Microbiol. 2020;11:2078. doi: 10.3389/fmicb.2020.02078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Design of a multi-epitope chimera from salivary proteins OBP 22 and OBP 10: a promising candidate vaccine. Sankar S. J Vector Borne Dis. 2022;59:327–336. doi: 10.4103/0972-9062.353271. [DOI] [PubMed] [Google Scholar]
- 24.Periodontal vaccines-a systematic review. Swarna Meenakshi, Sheeja S Varghese. Braz Dent Sci. 2020;23 [Google Scholar]



